Atricure Inc (NASDAQ: ATRC) kicked off on Monday, up 5.64% from the previous trading day, before settling in for the closing price of $34.41. Over the past 52 weeks, ATRC has traded in a range of $20.20-$43.11.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -0.33%. While this was happening, its average annual earnings per share was recorded 47.84%. With a float of $47.89 million, this company’s outstanding shares have now reached $49.69 million.
The extent of productivity of a business whose workforce counts for 1300 workers is very important to gauge. In terms of profitability, gross margin is 74.71%, operating margin of -6.82%, and the pretax margin is -7.05%.
Atricure Inc (ATRC) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Medical Instruments & Supplies Industry. The insider ownership of Atricure Inc is 3.64%, while institutional ownership is 100.53%. The most recent insider transaction that took place on May 28 ’25, was worth 83,600. In this transaction Chief Scientific Officer of this company sold 2,500 shares at a rate of $33.44, taking the stock ownership to the 73,550 shares. Before that another transaction happened on May 28 ’25, when Company’s Officer proposed sale 2,500 for $33.44, making the entire transaction worth $83,600.
Atricure Inc (ATRC) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 47.84% per share during the next fiscal year.
Atricure Inc (NASDAQ: ATRC) Trading Performance Indicators
Take a look at Atricure Inc’s (ATRC) current performance indicators. Last quarter, stock had a quick ratio of 2.83. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.61. Likewise, its price to free cash flow for the trailing twelve months is 74.59.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.77, a number that is poised to hit -0.11 in the next quarter and is forecasted to reach -0.22 in one year’s time.
Technical Analysis of Atricure Inc (ATRC)
The latest stats from [Atricure Inc, ATRC] show that its last 5-days average volume of 1.23 million was superior to 0.59 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 68.35%.
During the past 100 days, Atricure Inc’s (ATRC) raw stochastic average was set at 82.08%, which indicates a significant increase from 80.77% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.50 in the past 14 days, which was higher than the 1.43 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $32.48, while its 200-day Moving Average is $33.94.
